Investigational Site Number 840010

Ann Arbor, Michigan 48109-0759

0 studies enrolling now · 2 studies all time

What they study most

Hematopoietic Neoplasm

Studies at this site

• Phase II, Open Label, Single Arm Study of SAR302503 In Myelofibrosis Patients Previously Treated With Ruxolitinib — Stopped early
• Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia — Completed